Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Brexanolone Lifting Outcomes Of Moms

NCT ID: NCT07822321
Registry status: Recruiting
Study type: Not specified in the registry data
Phase: Phase 3
Sponsor: Lipocine Inc.

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 120 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Key Inclusion Criteria: * Are female between 15 and 45 years of age, inclusive; * Have had a depressive episode that began no earlier than second trimester and no later than the first 4 weeks following delivery * Are \< 18 months postpartum at Screening * Hamilton Depression Rating Scale (HAM-D) 17-item score indicative of severe depression Key Exclusion Criteria: * Have a history of bipolar disorder, schizophrenia or schizoaffective disorder * Are currently experiencing active psychosis per Investigator assessment * Have a history of suicidal behavior associated with the current depressive episode * Have a history of seizure within six months of Screening

Study locations

16 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

Arizona, United States: 1
California, United States: 2
Colorado, United States: 1
Georgia, United States: 1
Idaho, United States: 1
Illinois, United States: 1
Louisiana, United States: 1
Nevada, United States: 1
New Jersey, United States: 1
New York, United States: 1
North Carolina, United States: 1
Texas, United States: 2
Utah, United States: 2

Sample of listed locations

Lipocine Investigational Site — Tucson, Arizona, 85715, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Canoga Park, California, 91304, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Walnut Creek, California, 94596, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Aurora, Colorado, 80045, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Decatur, Georgia, 30030, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Idaho Falls, Idaho, 83402, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Chicago, Illinois, 60641, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — New Orleans, Louisiana, 70115, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Las Vegas, Nevada, 89119, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Princeton, New Jersey, 08540, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Manhattan, New York, 10036, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Chapel Hill, North Carolina, 27514, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Plano, Texas, 75093, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Richardson, Texas, 75080, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Clinton, Utah, 84105, United States — Site recruitment status not specified in the registry data
Lipocine Investigational Site — Orem, Utah, 84058, United States — Site recruitment status not specified in the registry data

Study details

Start date: September 1, 2026
Primary completion date: August 1, 2027
First posted: September 16, 2026

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07822321
Registry last updated: September 16, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT07822321 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Depression studies | Clinical trial FAQ